百洋医药：与济坤医药签署战略合作协议

Core Viewpoint - Baiyang Pharmaceutical has signed a strategic cooperation agreement with Jikun Pharmaceutical and its actual controller, aiming to enhance its product pipeline in the innovative drug sector through resource sharing [1] Group 1 - Baiyang Pharmaceutical plans to participate in a capital increase of Jikun Pharmaceutical, expecting to hold a 24% stake in the company [1] - The collaboration is intended to leverage the strengths of both companies in the innovative drug field [1] - The agreement is not expected to have a significant impact on Baiyang Pharmaceutical's operating performance for the current year, but it is anticipated to improve the company's sustainable profitability [1]